In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

R-Pharm CJSC

www.r-pharm.com/en

Latest From R-Pharm CJSC

Deal Watch: Boehringer, Epizyme Team Up To Develop Epigenetic Cancer Therapies

BI and Epizyme’s collaboration will focus on developing novel cancer drugs targeting helicase and HAT enzyme dysregulation. MorphoSys and I-Mab will partner on developing an IO therapy targeting C5aR.

Deals Business Strategies

TRPharm Chair: 'Dr Reddy's Partnership Is Key To International Expansion'

Turkey's TRPharm, in partnership with India's Dr Reddy's, has become the first company to gain a license for an oncology biosimilar Mab product in Turkey. Chairman Mehmet Göker spoke to Scrip about the company's international expansion plans.

Turkey Biosimilars

TRPharm Chair: 'Dr Reddy's Partnership Is Key To International Expansion'

Turkey's TRPharm, in partnership with India's Dr Reddy's, has become the first company to gain a license for an oncology biosimilar Mab product in Turkey. Chairman Mehmet Göker spoke to Scrip about the company's international expansion plans.

Turkey Biosimilars

TR-PHARM Sees Early Success In Mediterranean Fever Antibody

TR-PHARM, a Turkish affiliate of the leading Russian pharma company R-PHARM, has disclosed promising early results for clinical trials with a potential new biologic treatment for familial Mediterranean fever.

Turkey Research & Development
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Eastern Europe
        • Russia
  • Parent & Subsidiaries
  • R-Pharm CJSC
  • Senior Management
  • Vasily Ignatiev, MD, PhD, CEO
    Mikhail Samsonov, PhD, CSO
  • Contact Info
  • R-Pharm CJSC
    Phone: 495 956 79 37
    111B, Leninskiy prospect
    Moscow, 119421
    Russia
Advertisement
Advertisement
UsernamePublicRestriction

Register